HEADER TRANSFERASE/TRANSFERASE INHIBITOR 11-JAN-16 5HI2 TITLE BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH SORAFENIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTO-ONCOGENE B-RAF,P94,V-RAF MURINE SARCOMA VIRAL ONCOGENE COMPND 5 HOMOLOG B1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.M.WHALEN,S.A.FOSTER,A.OZEN,M.WONGCHENKO,J.YIN,G.SCHAEFER, AUTHOR 2 J.MAYFIELD,J.CHMIELECKI,P.STEPHENS,L.ALBACKER,Y.YAN,K.SONG, AUTHOR 3 G.HATZIVASSILIOU,C.EIGENBROT,C.YU,A.S.SHAW,G.MANNING,N.J.SKELTON, AUTHOR 4 S.G.HYMOWITZ,S.MALEK REVDAT 4 27-SEP-23 5HI2 1 REMARK REVDAT 3 03-AUG-16 5HI2 1 TITLE REMARK REVDAT 2 20-APR-16 5HI2 1 JRNL REVDAT 1 06-APR-16 5HI2 0 JRNL AUTH S.A.FOSTER,D.M.WHALEN,A.OZEN,M.J.WONGCHENKO,J.YIN,I.YEN, JRNL AUTH 2 G.SCHAEFER,J.D.MAYFIELD,J.CHMIELECKI,P.J.STEPHENS, JRNL AUTH 3 L.A.ALBACKER,Y.YAN,K.SONG,G.HATZIVASSILIOU,C.EIGENBROT,C.YU, JRNL AUTH 4 A.S.SHAW,G.MANNING,N.J.SKELTON,S.G.HYMOWITZ,S.MALEK JRNL TITL ACTIVATION MECHANISM OF ONCOGENIC DELETION MUTATIONS IN JRNL TITL 2 BRAF, EGFR, AND HER2. JRNL REF CANCER CELL V. 29 477 2016 JRNL REFN ISSN 1535-6108 JRNL PMID 26996308 JRNL DOI 10.1016/J.CCELL.2016.02.010 REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2_1309 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.56 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 10133 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1009 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.5662 - 4.8039 0.98 1370 152 0.1690 0.1986 REMARK 3 2 4.8039 - 3.8136 0.99 1322 144 0.1453 0.1949 REMARK 3 3 3.8136 - 3.3317 0.99 1301 145 0.1814 0.2260 REMARK 3 4 3.3317 - 3.0272 0.99 1303 145 0.2046 0.2618 REMARK 3 5 3.0272 - 2.8102 0.99 1277 142 0.2435 0.3414 REMARK 3 6 2.8102 - 2.6446 0.99 1285 143 0.2467 0.3386 REMARK 3 7 2.6446 - 2.5121 0.98 1266 138 0.2679 0.3484 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.030 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2063 REMARK 3 ANGLE : 1.188 2777 REMARK 3 CHIRALITY : 0.077 297 REMARK 3 PLANARITY : 0.004 353 REMARK 3 DIHEDRAL : 15.127 780 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 456 THROUGH 560 ) REMARK 3 ORIGIN FOR THE GROUP (A): 30.6212 15.0864 -14.8374 REMARK 3 T TENSOR REMARK 3 T11: 0.2208 T22: 0.3841 REMARK 3 T33: 0.1312 T12: -0.0037 REMARK 3 T13: 0.0098 T23: 0.0340 REMARK 3 L TENSOR REMARK 3 L11: 3.8289 L22: 1.8421 REMARK 3 L33: 2.7054 L12: -1.1651 REMARK 3 L13: -0.6838 L23: 0.9413 REMARK 3 S TENSOR REMARK 3 S11: -0.0101 S12: -0.2341 S13: 0.0669 REMARK 3 S21: 0.1402 S22: 0.0080 S23: -0.2465 REMARK 3 S31: 0.3112 S32: 0.2108 S33: 0.0025 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 561 THROUGH 721 ) REMARK 3 ORIGIN FOR THE GROUP (A): 12.3659 19.9774 -5.1395 REMARK 3 T TENSOR REMARK 3 T11: 0.2169 T22: 0.3645 REMARK 3 T33: 0.2194 T12: -0.0165 REMARK 3 T13: 0.0491 T23: -0.0486 REMARK 3 L TENSOR REMARK 3 L11: 3.1088 L22: 3.0956 REMARK 3 L33: 4.4041 L12: -0.2572 REMARK 3 L13: -0.9825 L23: 0.6952 REMARK 3 S TENSOR REMARK 3 S11: -0.2869 S12: -0.2321 S13: -0.0011 REMARK 3 S21: 0.3375 S22: 0.0346 S23: 0.1835 REMARK 3 S31: 0.0852 S32: -0.3247 S33: 0.2150 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HI2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000217044. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUL-15 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.953700 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN-COOLED DOUBLE REMARK 200 CRYSTAL, NON FIXED EXIT SLIT. REMARK 200 SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10142 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.510 REMARK 200 RESOLUTION RANGE LOW (A) : 45.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 6.610 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.13100 REMARK 200 FOR THE DATA SET : 12.4900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.180 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4MNE CHAIN B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, AND 0.2M POTASSIUM REMARK 280 NITRATE, PH 6.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.77200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.77200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 24.81250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 57.46000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 24.81250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 57.46000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 50.77200 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 24.81250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 57.46000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 50.77200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 24.81250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 57.46000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 436 REMARK 465 HIS A 437 REMARK 465 HIS A 438 REMARK 465 HIS A 439 REMARK 465 HIS A 440 REMARK 465 HIS A 441 REMARK 465 GLY A 442 REMARK 465 SER A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 ALA A 598 REMARK 465 THR A 599 REMARK 465 VAL A 600 REMARK 465 LYS A 601 REMARK 465 SER A 602 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 614 REMARK 465 GLY A 615 REMARK 465 GLN A 628 REMARK 465 ASP A 629 REMARK 465 SER A 630 REMARK 465 SER A 722 REMARK 465 GLY A 723 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 494 45.21 -95.30 REMARK 500 GLU A 545 -1.57 -56.06 REMARK 500 THR A 546 109.59 -50.73 REMARK 500 ARG A 575 -21.21 79.78 REMARK 500 ASP A 587 -6.72 72.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BAX A 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5HIE RELATED DB: PDB REMARK 900 BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH REMARK 900 DABRAFENIB REMARK 900 RELATED ID: 5HID RELATED DB: PDB REMARK 900 BRAF KINASE DOMAIN B3AC LOOP DELETION MUTANT IN COMPLEX WITH AZ628 DBREF 5HI2 A 444 723 UNP P15056 BRAF_HUMAN 444 723 SEQADV 5HI2 MET A 436 UNP P15056 INITIATING METHIONINE SEQADV 5HI2 HIS A 437 UNP P15056 EXPRESSION TAG SEQADV 5HI2 HIS A 438 UNP P15056 EXPRESSION TAG SEQADV 5HI2 HIS A 439 UNP P15056 EXPRESSION TAG SEQADV 5HI2 HIS A 440 UNP P15056 EXPRESSION TAG SEQADV 5HI2 HIS A 441 UNP P15056 EXPRESSION TAG SEQADV 5HI2 GLY A 442 UNP P15056 EXPRESSION TAG SEQADV 5HI2 SER A 443 UNP P15056 EXPRESSION TAG SEQADV 5HI2 A UNP P15056 ASN 486 DELETION SEQADV 5HI2 A UNP P15056 VAL 487 DELETION SEQADV 5HI2 A UNP P15056 THR 488 DELETION SEQADV 5HI2 A UNP P15056 ALA 489 DELETION SEQADV 5HI2 A UNP P15056 PRO 490 DELETION SEQADV 5HI2 ALA A 543 UNP P15056 ILE 543 ENGINEERED MUTATION SEQADV 5HI2 SER A 544 UNP P15056 ILE 544 ENGINEERED MUTATION SEQADV 5HI2 LYS A 551 UNP P15056 ILE 551 ENGINEERED MUTATION SEQADV 5HI2 ARG A 562 UNP P15056 GLN 562 ENGINEERED MUTATION SEQADV 5HI2 ASN A 588 UNP P15056 LEU 588 ENGINEERED MUTATION SEQADV 5HI2 SER A 630 UNP P15056 LYS 630 ENGINEERED MUTATION SEQADV 5HI2 GLU A 667 UNP P15056 PHE 667 ENGINEERED MUTATION SEQADV 5HI2 SER A 673 UNP P15056 TYR 673 ENGINEERED MUTATION SEQADV 5HI2 ARG A 688 UNP P15056 ALA 688 ENGINEERED MUTATION SEQADV 5HI2 SER A 706 UNP P15056 LEU 706 ENGINEERED MUTATION SEQADV 5HI2 ARG A 709 UNP P15056 GLN 709 ENGINEERED MUTATION SEQADV 5HI2 GLU A 713 UNP P15056 SER 713 ENGINEERED MUTATION SEQADV 5HI2 GLU A 716 UNP P15056 LEU 716 ENGINEERED MUTATION SEQADV 5HI2 GLU A 720 UNP P15056 SER 720 ENGINEERED MUTATION SEQADV 5HI2 SER A 722 UNP P15056 PRO 722 ENGINEERED MUTATION SEQADV 5HI2 GLY A 723 UNP P15056 LYS 723 ENGINEERED MUTATION SEQRES 1 A 283 MET HIS HIS HIS HIS HIS GLY SER ARG ASP SER SER ASP SEQRES 2 A 283 ASP TRP GLU ILE PRO ASP GLY GLN ILE THR VAL GLY GLN SEQRES 3 A 283 ARG ILE GLY SER GLY SER PHE GLY THR VAL TYR LYS GLY SEQRES 4 A 283 LYS TRP HIS GLY ASP VAL ALA VAL LYS MET LEU THR PRO SEQRES 5 A 283 GLN GLN LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU SEQRES 6 A 283 ARG LYS THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY SEQRES 7 A 283 TYR SER THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP SEQRES 8 A 283 CYS GLU GLY SER SER LEU TYR HIS HIS LEU HIS ALA SER SEQRES 9 A 283 GLU THR LYS PHE GLU MET LYS LYS LEU ILE ASP ILE ALA SEQRES 10 A 283 ARG GLN THR ALA ARG GLY MET ASP TYR LEU HIS ALA LYS SEQRES 11 A 283 SER ILE ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE SEQRES 12 A 283 LEU HIS GLU ASP ASN THR VAL LYS ILE GLY ASP PHE GLY SEQRES 13 A 283 LEU ALA THR VAL LYS SER ARG TRP SER GLY SER HIS GLN SEQRES 14 A 283 PHE GLU GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO SEQRES 15 A 283 GLU VAL ILE ARG MET GLN ASP SER ASN PRO TYR SER PHE SEQRES 16 A 283 GLN SER ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU SEQRES 17 A 283 LEU MET THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN SEQRES 18 A 283 ARG ASP GLN ILE ILE GLU MET VAL GLY ARG GLY SER LEU SEQRES 19 A 283 SER PRO ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS SEQRES 20 A 283 ARG MET LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS SEQRES 21 A 283 ARG ASP GLU ARG PRO SER PHE PRO ARG ILE LEU ALA GLU SEQRES 22 A 283 ILE GLU GLU LEU ALA ARG GLU LEU SER GLY HET BAX A 801 32 HETNAM BAX 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL) HETNAM 2 BAX PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE- HETNAM 3 BAX 2-CARBOXAMIDE HETSYN BAX SORAFENIB FORMUL 2 BAX C21 H16 CL F3 N4 O3 FORMUL 3 HOH *29(H2 O) HELIX 1 AA1 THR A 491 GLN A 493 5 3 HELIX 2 AA2 GLN A 494 ARG A 506 1 13 HELIX 3 AA3 SER A 536 ALA A 543 1 8 HELIX 4 AA4 GLU A 549 LYS A 570 1 22 HELIX 5 AA5 LYS A 578 ASN A 580 5 3 HELIX 6 AA6 GLU A 586 ASN A 588 5 3 HELIX 7 AA7 SER A 616 MET A 620 5 5 HELIX 8 AA8 ALA A 621 MET A 627 1 7 HELIX 9 AA9 SER A 634 GLY A 652 1 19 HELIX 10 AB1 ASN A 661 GLY A 672 1 12 HELIX 11 AB2 ASP A 677 VAL A 681 5 5 HELIX 12 AB3 PRO A 686 LEU A 697 1 12 HELIX 13 AB4 SER A 706 ARG A 719 1 14 SHEET 1 AA1 5 THR A 458 GLY A 466 0 SHEET 2 AA1 5 GLY A 469 LYS A 475 -1 O VAL A 471 N ILE A 463 SHEET 3 AA1 5 ASP A 479 LEU A 485 -1 O MET A 484 N THR A 470 SHEET 4 AA1 5 LEU A 525 GLN A 530 -1 O LEU A 525 N LEU A 485 SHEET 5 AA1 5 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528 SHEET 1 AA2 2 ILE A 582 HIS A 585 0 SHEET 2 AA2 2 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 CISPEP 1 LYS A 522 PRO A 523 0 -5.18 SITE 1 AC1 16 VAL A 471 ALA A 481 GLU A 501 LEU A 505 SITE 2 AC1 16 ILE A 513 LEU A 514 THR A 529 GLN A 530 SITE 3 AC1 16 CYS A 532 LEU A 567 HIS A 574 PHE A 583 SITE 4 AC1 16 ILE A 592 GLY A 593 ASP A 594 PHE A 595 CRYST1 49.625 114.920 101.544 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020151 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008702 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009848 0.00000